Among secondary haemodynamic endpoints , a highly significant reduction in pulmonary artery pressure ( PAP ) was observed throughout the serelaxin infusion ( largest difference in mean PAP vs. placebo : -5.17 mmHg at 4 h , P < 0.0001 ) .